"Cancer center in Houma, LA, a partnership with Terrebonne General Health System. Mary Bird Perkins Cancer Center in Houma offers residents in the Bayou Region access to leading-edge radiation therapy, diagnostic imaging and key supplemental services in a comfortable, supportive setting. Together, Mary Bird Perkins Cancer Center and Terrebonne General Medical Center provide patients with compassionate, comprehensive cancer care, close to home."

During the past decade, Mary Bird Perkins Cancer Center - Houma conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 16 clinical trials were completed, i.e. on average, 59.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 13 clinical trials were completed. i.e. 325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Bird Perkins Cancer Center - Houma" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Bird Perkins Cancer Center - Houma" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mary Bird Perkins Cancer Center - Houma" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Adenocarcinoma" (2 trials), "Breast Cancer" (2 trials) and "Breast Carcinoma" (2 trials). Many other conditions were trialed in "Mary Bird Perkins Cancer Center - Houma" in a lesser frequency.

Most popular intervention types in "Mary Bird Perkins Cancer Center - Houma" are "Other" (29 trials), "Drug" (28 trials), "Biological" (13 trials), "Procedure" (8 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (6 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mary Bird Perkins Cancer Center - Houma" are 36 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Bird Perkins Cancer Center - Houma". undefined are not yet recruiting, 8 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Mary Bird Perkins Cancer Center - Houma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mary Bird Perkins Cancer Center - Houma, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".